In summary, we uncover alterations in energy metabolism in TDP43<sup>G376D</sup> patient-derived primary fibroblasts that may be used as risk biomarkers and/or to monitor ALS progression. Here, TARDBP is linked to amyotrophic lateral sclerosis.